Breast Cancer Risks Working Women Should Know After Chef's Diagnosis
What Women Need to Know About Fertility Between Ages 35 and 40
Eczema's Hidden Impact: How Atopic Dermatitis Shapes Life Paths
Michigan Woman Receives First Combined Intestinal-Kidney Transplant
What's New?
Must Reads
More on medicalnewscorner
Graphene Dots Show Promise Against Parkinson's Protein Buildup
May 25, 2026
New research reveals graphene quantum dots may interfere with toxic protein clumping in Parkinson's disease, offering hope for targeting underlying disease...
Scientist Joins Prestigious Medical Sciences Fellowship
May 21, 2026
A leading medical scientist has been elected to an elite academy, recognising a distinguished career in biomedical research, evidence-based healthcare, collaboration, and discoveries with real-world impact.
Perimenopause: Key Time to Lower Heart Disease Risk
May 18, 2026
Perimenopause is a key window to protect heart health by tracking blood pressure, cholesterol, glucose, sleep, and lifestyle habits before cardiovascular risks become harder to reverse.
FDA Proposes Ban on Bulk Semaglutide and Tirzepatide Compounding
May 11, 2026
The FDA is considering tighter limits on compounded semaglutide and tirzepatide, raising questions about safety, access, cost, and the future of copycat GLP-1 weight loss and diabetes medications.
Perimenopause Signs and Management Tips From an OB-GYN
May 7, 2026
Perimenopause can bring irregular periods, hot flashes, sleep problems, mood shifts, and weight changes. A practical plan combining nutrition, exercise, sleep support, stress management, and medical care can ease symptoms and protect long-term health.
Moderate Alcohol Use Damages Brain Health, Study Finds
May 4, 2026
New research suggests even light or moderate alcohol use may affect brain structure over time, raising concerns about memory, cognitive aging, and long-term brain health.
Targeting Stem-Like Cells May Prevent Colorectal Cancer Recurrence
April 29, 2026
New research suggests stem-like colorectal cancer cells may survive treatment, remain dormant, and later drive recurrence, highlighting the need for better biomarkers, follow-up, and therapies targeting hidden residual disease.
GLP-1s Ineffectiveness: Reasons and Solutions Explained
April 16, 2026
GLP-1 receptor agonists are popular for type 2 diabetes and obesity management, but their effectiveness varies due to genetics, lifestyle, and insulin resistance. Personalized care and alternative treatments can help those who find these medications less effective.